Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer

Clinical trial NCT01609127 · UNKNOWN

Trial details

NCT number: NCT01609127
Sponsor: Genta Incorporated
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Non-resectable Breast Cancer Metastatic Breast Cancer

Start date: 2012-05-01
Primary completion: 2013-09-01
Enrollment: 213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.